-transparent.png){kind=logo}
Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma. 1994
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
Department of Nuclear Medicine and Biophysics, L.E.R., URA CNRS 1287, U.F.R. de Médecine, La Tronche, France.
28 patients with primitive lung cancers were imaged by immunoscintigraphy (IS) with 111indium-labelled F(ab')2 anti-carcinoembryonic antigen (CEA), to assess this technique for mediastinal staging. IS revealed primitive tumours in 21 cases in whom mediastinal extension was assessed. There was concordance between clinical staging and IS confirmed by surgery in 17 cases, and discordance in 4. After surgery, discordance was in favour of IS in 2 cases (1 true positive and 1 true negative) and in favour of clinical staging in 2 (false positive of immunoscintigraphy). Anti-CEA IS could be useful for improving mediastinal staging of lung cancer.
Related Publications
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
August 1988,
Nuclear medicine communications,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
January 1987,
Cancer detection and prevention,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
November 1991,
Nuclear medicine communications,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
January 1987,
Rays,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
January 1992,
The Journal of clinical endocrinology and metabolism,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
January 1986,
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
June 1993,
British journal of cancer,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
March 1992,
Nuclear medicine communications,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
April 1988,
Cancer research,
J P Vuillez, and
D Moro, and
E Brambilla, and
P Y Brichon, and
G Ferretti, and
J C Saccavini, and
C Brambilla
June 1989,
Cancer research,
